Abstract 1626: CDK9 inhibition enhances apoptosis of TP53 mutated AML when combined with standard chemotherapy - KIVIRID

Abstract 1626: CDK9 inhibition enhances apoptosis of TP53 mutated AML when combined with standard chemotherapy

Authors: Elizabeth C. Trull, David B. Sykes, Philip C. Amrein

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-1626

Source: Full article

Abstract

Abstract